SUMMARY. It has generally been assumed, from assessment of myocardial metabolism with [l-n C]palmitate and positron emission tomography, that clearance of the radiolabel from the myocardium is attributable solely to efflux of the products of oxidative metabolism. However, interpretations would differ if this assumption were unfulfilled. Furthermore, efflux of metabolized and nonmetabolized tracer has not been quantified. Accordingly, in this study, myocardium was perfused extracorporeally in 21 open-chest anesthetized dogs, and the extraction and clearance of [l-"C]palmitate were characterized under baseline conditions (normoxia, n = 21), and, again, with ischemia (n = 6), with hypoxia (n = 9), or under control conditions (n = 6). After intracoronary bolus injection of [l-1 1 C]palrnitate, myocardial time activity curves were measured with a /S-probe, and the products of oxidative metabolism ( n CO2) and efflux of extracted but nonmetabolized fatty acid ('back-diffusion' of [ln C]palmitate) were measured directly from analysis of arterial and regional coronary venous blood. Under control conditions, 45.2 ± 3.8% (mean ± SD) of initially extracted [1-C]palmitate was metabolized to "CO2, whereas 6.2 ± 2.6% back-diffused in unaltered form in 1-10 minutes, In contrast, with ischemia (perfusion of 26% of baseline), only 16.9 ± 9.8% of administered tracer evolved as n CO 2 (P < 0.001 compared with control) but 15.6 ± 8.9% (i.e., almost half of the total amount cleared) evolved unaltered as [ln C]palmitate (P < 0.05). Similarly, with hypoxia, 15.1 ± 8.4% evolved as "CO 2 (P < 0.0001) and 18.8 ± 11.7% back-diffused (P < 0.001). Overall, from 1-40 minutes after intracoronary injection of tracer, back-diffusion of [l^'C^palmitate contributed 40.6% of total radioactivity in the effluent with ischemia, 48.7% with hypoxia, but only 8.9% under control conditions. Despite the increased back-diffusion of [l-"C]palmitate seen with ischemia and hypoxia, the overall residue of C activity in myocardium increased, consistent with the diminished clearance observed in the myocardial time-activity curves and the increase in the tissue content of triglyceride and nonesterified fatty acid. Our results indicate that estimates of oxidative metabolism based upon clearance of radiolabeled fatty acid must take into account the efflux of initially extracted but nonmetabolized fatty acid. The findings apply to external determination of oxidative metabolism of the heart with any imaging modality that delineates retention and clearance of labeled fatty acids or their analogs. (Circ Res 57: 232-243, 1985) 
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From the Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri SUMMARY. It has generally been assumed, from assessment of myocardial metabolism with [ln C]palmitate and positron emission tomography, that clearance of the radiolabel from the myocardium is attributable solely to efflux of the products of oxidative metabolism. However, interpretations would differ if this assumption were unfulfilled. Furthermore, efflux of metabolized and nonmetabolized tracer has not been quantified. Accordingly, in this study, myocardium was perfused extracorporeally in 21 open-chest anesthetized dogs, and the extraction and clearance of [l-"C]palmitate were characterized under baseline conditions (normoxia, n = 21), and, again, with ischemia (n = 6), with hypoxia (n = 9), or under control conditions (n = 6). After intracoronary bolus injection of [l-1 1 C]palrnitate, myocardial time activity curves were measured with a /S-probe, and the products of oxidative metabolism ( n CO2) and efflux of extracted but nonmetabolized fatty acid ('back-diffusion' of [l- n C]palmitate) were measured directly from analysis of arterial and regional coronary venous blood. Under control conditions, 45.2 ± 3.8% (mean ± SD) of initially extracted [1-C]palmitate was metabolized to "CO2, whereas 6.2 ± 2.6% back-diffused in unaltered form in 1-10 minutes, In contrast, with ischemia (perfusion of 26% of baseline), only 16.9 ± 9.8% of administered tracer evolved as n CO 2 (P < 0.001 compared with control) but 15.6 ± 8.9% (i.e., almost half of the total amount cleared) evolved unaltered as [l- n C]palmitate (P < 0.05). Similarly, with hypoxia, 15.1 ± 8.4% evolved as "CO 2 (P < 0.0001) and 18.8 ± 11.7% back-diffused (P < 0.001). Overall, from 1-40 minutes after intracoronary injection of tracer, back-diffusion of [l^'C^palmitate contributed 40.6% of total radioactivity in the effluent with ischemia, 48.7% with hypoxia, but only 8.9% under control conditions. Despite the increased back-diffusion of [l-"C]palmitate seen with ischemia and hypoxia, the overall residue of C activity in myocardium increased, consistent with the diminished clearance observed in the myocardial time-activity curves and the increase in the tissue content of triglyceride and nonesterified fatty acid. Our results indicate that estimates of oxidative metabolism based upon clearance of radiolabeled fatty acid must take into account the efflux of initially extracted but nonmetabolized fatty acid. The findings apply to external determination of oxidative metabolism of the heart with any imaging modality that delineates retention and clearance of labeled fatty acids or their analogs. (Circ Res 57: 232-243, 1985) BY delineating regional myocardial extraction and clearance of substrates, positron emission tomography with carbon-11-, oxygen-15-, or nitrogen-13-labeled metabolic substrates offers promise for quantification of regional myocardial metabolism (Sobel, 1978; Ter-Pogossian et al., 1980; Schelbert et al., 1982) . However, interpretation of the significance of extraction and clearance of a radiolabeled substrate requires elucidation of the fate of the tracer. One particularly important yet inadequately defined determinant is the extent to which egress of nonmetabolized substrate contributes to overall, observed clearance. The quantitative contributions of efflux from the heart of metabolized and nonmetabolized tracers of fatty acids have not previously been defined.
Free fatty acids are the primary physiological substrate for oxidative, myocardial energy production (Neely et al., 1972; Opie, 1976) . Decreased fatty acid oxidation is an early consequence of ischemia (Scheuer et al., 1966; Liedtke et al., 1975; van der Vusse et al, 1982; Lerch et al., 1982a) . Accordingly, fatty acids or fatty acid analogs labeled with radioactive isotopes have been employed widely for noninvasive delineation of myocardial metabolism (Weiss et al., 1976; Klein et al., 1979; Lerch et al., 1981; Elmaleh et al., 1981; livni et al., 1982; Schon et al., 1982a Schon et al., , 1982b . n C]palmitate or * 11 C-P') has biochemical properties identical to those of its physiological counterpart. The kinetics of myocardial accumulation and clearance of n C-P have been measured externally in isolated hearts and in open-chest and intact animals (Klein et al., 1979; Lerch et al., 1981; Schon et al., 1982a Schon et al., , 1982b , and in hearts of patients studied with positron tomography (Ter-Pogossian et al., 1980; Schelbert et al., 1982) . However, interpretation of the biological significance of tomographically detected clearance of extracted n C-labeled fatty acid must take into account the extent to which efflux of the radiolabeled tracer can be attributed to egress of oxidative metabolites per se, on the one hand, and to nonmetabolized but initially extracted labeled fatty acid, on the other. Egress of tracer from myocardium in the form of CO 2 has often been assumed to be the sole component responsible for net clearance of tracer. However, if a significant proportion of the extracted fatty acid back-diffuses from myocardium without being metabolized, inferences regarding the rate of oxidation based on measured overall clearance would require modification.
We have previously shown that viable but ischemic myocardium in the region of supply of a stenotic coronary artery continues to extract n C-P (Lerch et al., 1982a) but exhibits a diminished rate of overall clearance of the tracer. The diminution of clearance delineated by residue detection has been generally interpreted to reflect decreased oxidation, and the slope of early rapid clearance phase has been interpreted as reflecting the extent of /3-oxidation (Lerch etal., 1982a; Schon et al., 1982a Schon et al., , 1982b . However, such interpretations may be spurious in the absence of characterization of the extent to which the initially extracted fatty acid is oxidatively metabolized, the extent to which it remains within the cytosol as free or esterified fatty acid or in the neutral or phospholipid pools, and the extent to which it back-diffuses from myocardium without being metabolized at all. Rose and Goresky, (1977) , have investigated the constraints of uptake of labeled fatty acid with respect to intravascular and interstitial markers. However, their studies have not been extended to characterize residue clearance with respect to the fate of extracted tracer in myocardium and the quantitative contributions of efflux of oxidatively metabolized tracer and washout of initially extracted but not metabolized fatty acid. Interpretation of the biological implications of clearance of tracer requires such information. Accordingly, this study was undertaken to determine the quantitative significance of efflux of the components of labeled fatty acid in relation to net content of n C activity in myocardium. The information acquired should be applicable not only to assessment of myocardial metabolism by positron emission tomography, but also to interpretation of kinetics of tracers of fatty acid metabolism based on results obtained with any modality that externally detects the distribution of labeled substrate in myocardium.
The specific objectives were as follows: (1) quantify the respective contributions of n CO 2 derived from oxidative metabolism of n C-P and of efflux of 233 unaltered n C-P (back-diffusion) to the net clearance of radiolabeled fatty acid tracer from myocardium; (2) define the extent to which altered clearance of [ n C]palmitate in normal, ischemic, and hypoxic myocardium reflects oxidative metabolism of C-P measured directly; (3) define the quantitative contributions from tracer in specific lipid pools within myocardium during the imaging interval in relation to efflux of n C-P and to egress of n QO^ and (4) elucidate the extent to which the efflux of nonmetabolized fatty acid influences the interpretation of integrated positron emission tomograms or apparent clearance delineated with sequentially obtained tomograms.
Methods

Animal Preparations
In order to characterize the kinetics of fatty acid clearance from myocardium and fatty acid utilization assessed radiochemically at the same time, and to delineate rates of oxidation of fatty acid, we used open-chest, anesthetized dogs. Animals were subjected to coronary artery cannulation to permit regional perfusion at selected flows. Twenty-one mongrel dogs, weighing 26-43 kg, were premedicated with morphine sulfate, 1 mg/kg (sc), after an overnight fast. Anesthesia was induced with sodium thiopental, 12 mg/kg, iv, and was maintained with a-chloralose, 60 mg/kg. Animals were intubated and ventilated (Harvard respiratory model 607) with room air enriched with oxygen to maintain arterial Po? greater than 90 mm Hg. A left thoracotomy was performed at the 5th intercostal space, and the heart was suspended in a pericardia! cradle. The left anterior descending coronary artery (LAD) or the circumflex coronary artery (L.CX) was dissected free within 1 cm from its origin. Heparin, 400 U/kg, was administered intravenously.
An extracorporeal bypass system was employed to permit independent control of coronary flow under conditions of normoxia, ischemia, or hypoxia (Lerch et al., 1982a) . Blood from the femoral artery was passed through the extracorporeal bypass system (total volume, 75 ml) with the use of a calibrated roller pump (Buchler Instruments), a heat exchanger, and a Swank transfusion filter with 13-jjm exclusion. Aortic and perfusion pressures were monitored continuously with Statham P23Db transducers. Perfusion pressure calibration measurements were obtained with each dog's own blood and were corrected for the small pressure gradient in the coronary cannula at the flow rates used in each experiment. The proximal LAD or LCX was cannula ted with an 18-gauge polyethylene cannula, and the vessel was perfused by the extracorporeal bypass system. The native vessel proximal to the site of cannulation was ligated so that perfusion in the distribution of the cannulated vessel was derived solely from the bypass system (Lerch et al., 1982a) . Interruption of blood flow through the vessel during the cannulation procedure did not exceed 1 minute. Perfusion pressure was adjusted to match aortic diastolic pressure. The epicardial electrocardiogram from the center of the zone supplied by the cannulated vessel was monitored continuously. Normal saline was infused to match the combined volumes of the extracorporeal bypass system and the total volume of samples withdrawn (approximately 150 ml). A 20-gauge polyethylene cannula was inserted into the epicardial vein draining the perfused region of myocardium for subsequent blood sampling.
Regional Myocardial Utilization of Substrate
Regional myocardial oxygen utilization (MVO 2 ) in the zone of extracorporeal perfusion was calculated based on oxygen content (including dissolved O 2 ), in arterial and local coronary venous blood samples and flow. Hemoglobin concentration and oxygen saturation were assayed serially with a model IL182 Instrumentation Laboratory oximeter. Po^ Pco^ and pH were assayed with a model 213 Instrumentation Laboratory blood gas analyzer. For calculation of unlabeled glucose, lactate, oxygen, and fatty add utilization, perfusate and coronary venous samples were taken 10 and 40 minutes after administration of radiotracer. Plasma lactate was assayed enzymatically (Gutmann and Wahlefeld, 1984) , and plasma glucose, spectrophotometrically (Komberg and Horecker, 1955) (Calbiochem-Behring reagents). Concentrations of nonesterified fatty add (FFA) were measured in duplicate colorimetrically (Bergmann et al., 1982) . To define further the changes in individual fatty adds with each intervention, thin layer chromatography and gas chromatography were performed on lipid extracts from myocardial tissue, permitting measurement of fatty add content and pool size of. myocardial lipids. Organic extracts of tissue were spiked with an internal standard of heptadecanoic add (C17:0), and subjected to thin layer chromatography in petroleum ether, diethyl ether, and acetic add (97:52:3) to separate FFA and triglycerides. FFA were further characterized after elution from the silica and esterification with boron trifluoride-methanol. The resulting fatty add methyl esters were extracted into iso-octane and analyzed by gas chromatography (HP 57904), using a 2 mm X 2 meter glass column (SP 2330 10%, Supleco). Triglyceride was quantified spectrophotometrically after elution from silica (Van Handel and Zilversmit, 1957) .
In seven experiments [1 -14 C]palmitate was administered simultaneously with the [ln C|palmitate to characterize fhe distribution of the radiotracer in the efflux. Thin layer chromatography, high pressure liquid chromatography, and liquid scintillation spectrometry were utilized to characterize the chemical form of radiotracer in the efflux from the extracorporeally perfused region of the heart. Rapidly frozen tissue samples were obtained at the end of each study and were assayed for fatty add and triglyceride content. Gas chromatography was performed to determine the fatty add composition of components in the lipid extract.
Preparation of Radiolabeled Palmitate and Radiolabeled Water
[l-"C]Palmitate was synthesized as described previously (Welch et al., 1983) with the use of a remotely controlled automated system in which the [ln C)palmitate is produced from n CO 2 obtained through the 14 N[p, d ]"C nudear reaction. Cydotron-produced CO 2 was reacted with the Grignard reagent, n-pentadecyl magnesium bromide diethyl ether. The palmitic add produced was added to a 3% solution of human serum albumin in normal saline and filtered through 0.45-and 0. 
Experimental Protocol
Three groups of animals were studied. In each, baseline measurements preceded interventions. To characterize the physiological stability of the experimental animal preparation, a control group of six animals was studied initially. Analyses of tracer kinetics and substrate utilization (FFA, glucose, O^ lactate) were repeated 90 minutes after the baseline study in the absence of any intervention in each of these animals (the control group).
In another group of six animals, ischemia was induced after baseline analysis by reduction of perfusion in the extracorporeal circuit to 10% of baseline pump flow. Thirty minutes later, tracer kinetic and substrate utilization analyses were repeated, i.e., beginning 90 minutes after the baseline injection of tracer (the ischemic group).
In a third group of nine animals, hypoxia without reduction of flow was induced after the baseline study by initiating perfusion with venous instead of arterial blood without any alteration of pump flow. Thirty minutes later, a repeat study was performed in each dog. In these animals (the hypoxic group), samples were taken from the perfusate so that the "a'-v extraction of glucose, lactate, and fatty adds could be determined.
After cannulation and bypass perfusion, a 30-minute stabilization interval was imposed for each of the dogs prior to each baseline study. To measure nutritional perfusion (induding contributions from collateral supply), we injected 2-4 mCi of H 2 "O, ic, as a bolus over 1-2 seconds in a volume of 0.25 ml of blood, as described previously (Lerch et al., 1982a; Bergmann et al., 1984) . Myocardial H 2
15
O residue time activity curves were obtained with the use of a /3-probe. Five minutes after the injection of H 2 "O, 4-6 mCi of [ln C]palmitate were injected as a bolus over 1 second, ic, in a volume of 0.25 ml, and time-activity curves were obtained for 20 minutes. Simultaneous perfusate and coronary venous blood samples were taken every minute for 10 minutes, every 2 minutes up to 20 minutes, and, subsequently, every 5 minutes up to 40 minutes. Additional perfusate and coronary venous samples were obtained 10 minutes and 40 minutes after injection of tracer for chemical analysis of fatty add content, determination of blood gases and pH, and assay of lactate and glucose.
Immediately before the termination of each study, 5 ml of lissamine green dye were injected via the perfusion cannula, followed by intracoronary KG to delineate the zone of perfusion and to induce cardiac arrest. Animals with branches of the draining coronary vein arising from areas that induded zones of native perfusion, or animals in which the probe's area within the field of view overlapped the zone of native perfusion, were exduded (n = 2).
Analysis of Regional Myocardial Tracer Time-Activity Curves
Myocardial residue tracer time-activity curves were determined for oxygen-15-labeled water (isotope t* = 2.1 minutes) and [1-CJpalmitate (isotope t* = 20.4 minutes) with the use of a /3-probe aligned between two arterial branches in the zone perfused by the extracorporeal bypass system. The high effidency for detection of /3-radiation with this system has been documented previously (Lerch et al., 1982b) . The contribution of -y-photons from an external source averaged 3.5%. However, the contribution of -y-photons from the heart was higher (30-35% of total activity detected) because of greater intrinsic atten-
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uation of positrons compared with 7-photons from heart muscle.
To estimate the contribution of recirculated tracer activity to total counts detected by the probe, we performed separate studies in which tracer of constant specific activity in a constant volume was injected via the right atrium. The mean interval from the time of injection into the right atrium to the time of occurrence of peak activity recorded by the probe over the left ventricle (LV) was 9 seconds (range, 7-11 seconds). However, the contribution of recirculating activity to probe counts did not exceed 3% of counts detected after intracoronary administration in any of the experiments (three dogs, 15 determinations). Because the contribution of recirculating activity to probe counts was so small, no corrections for retircuiation were required.
The output from the probe was fed into an Ortec amplifier (model 485) and a pulse height analyzer (Ortec model 488). Count rates were monitored with a rate meter and collected with the aid of a microcomputer. The computer corrected observed activity for physical decay of the isotope and provided a printout of regional time-activity curves.
Calculations of the myocardial turnover rate constant (k), biological half-time (t*), and correlation coefficient (r) for characterization of the slope of specified portions of H 2 "O and ["CJpalmitate time-activity curves were performed with the aid of the microcomputer, using the least squares approximation of the natural logarithm of the count rate as a function of time (Lerch et al., 1982b) . Myocardial blood flow was determined based on the slope of the monoexponential H 2
15
O washout during the interval from 15-30 seconds after injection of the tracer. Flow was calculated from the clearance rate multiplied by 0.92 (the myocardial tissue:blood partition coefficient for water), as described previously (Bergmann et al., 1984) . Clearance of "C activity after the early, rapid, vascular phase was determined from selected portions of the timeactivity curve. Extraction fraction was determined by back extrapolation of the early component of the time activity curve (from 1-3 minutes after tracer administration) to the time of occurrence of peak counts. The extraction fraction was expressed as residue counts divided by peak counts. We have previously shown that extraction of tracer measured in this fashion correlates closely with arteriovenous extraction measured directly (Nomura et al., 1982) .
Differentiation of Efflux of Oxidative Products from Efflux of Norunetabolized Tracer
For quantitative determination of the respective contributions to total radioactivity of n CC>2 and "C-P in each of the arterial and coronary venous samples, the following procedure was employed. Two 1.0-ml aliquots of arterial and two 1.0-ml aliquots of coronary venous blood samples were placed into tubes containing 3 ml of isopropyl alcohol and 1.0 ml of 0.9 M sodium bicarbonate. One ml of 6 N HC1 was added to one member of each pair and 1 ml of 0.1 N NaOH was added to the other. Both samples were placed in a heated (85°C) ultrasonic bath and disrupted sonically in a fume hood for 10 minutes. Radioactivity in the samples was assayed with a 7-well counter with correction for isotope decay. Acid treated samples of' 'CO 2 standards in blood released more than 96% of total CO 2 (n = 20 (Fox et al., 1983) were virtually identical to those obtained with "CO 2 .
Quantification of the Contributions of "CCh and "C-P Efflux
The following outline for the analysis of the contributions of individual components to clearance of the radiotracer ( ll C) was adopted:
where H C[Tp] = throughput of "C activity (%) and n C[R] = "C activity retained in tissue (%) on first pass. At time t':
where "C[CO 2 ], "C[P] are the concentrations of "C activity in the efflux, measured as n CO 2 or ["CJpalmitate from time t to time t' (shown to be the only forms of tracer in the effluent); and n C[R]t' = residue of "C activity in tissue at time t' (as FFA, phospholipid, triglyceride, and with small components of mono-and diglycerides); F = flow (ml/100 g per min). This approach is based upon the methods for estimating tracer washout, as discussed by Bassingthwaighte (1977) .
To assess the quantitative significance of the efflux of the two forms of the radiotracer ( n CO 2 and "C-P) with respect to residue detection tracer time-activity curves, summated values were calculated and expressed in terms of initially extracted "C-P. The n CO 2 and "C-P measurements in vitro were summed over the 1-to 20-minute interval and referenced to myocardial probe counts throughout the same interval. The 1-minute residue detection activity was chosen for the first point of reference to avoid the influence of initial vascular transit and to precede the onset of appreciable "CO 2 efflux. The summed efflux values for CO 2 and ["C]palmitate were expressed relative to the decline of counts detected by the probe during the entire interval.
Thus: (1) the respective contributions of activity from "CO 2 and ["C]palmitate to total radioactivity in the efflux was calculated for the entire data collection period from t = 0 minute to t = 40 minutes; (2) the summed radioactivity in the efflux for the intervals from 1-10, 10-20, and 20-40 minutes was calculated for "CO 2 and for [ " q palmitate. Values were expressed as fractions of the total myocardial residue activity detected by the probe at 1 minute to provide an index of efflux of tracer as a percentage of initially extracted ["CJpalmitate.
Statistical Analysis
Values are expressed as means ± SD. The /-test for paired samples was used to compare intragroup baseline values with those after interventions. Further comparisons were performed by linear regression analysis and by analysis of variance.
Results
Hemodynamics, Perfusion, and Oxygen Consumption
Hemodynamics and myocardial oxygen consumption (MVO2) were characterized to determine whether cardiac work was similar under normoxic baseline conditions in the three groups, to determine whether it was consistent with perfusion maintained constant in the control group, and to characterize changes with hypoxia without reduction of flow and with ischemia.
Myocardial blood flow, MVO2, and perfusion pressure did not differ among the three groups under baseline conditions (Table 1 ). There were no significant changes in heart rate or aortic systolic or diastolic pressures in the control group or with ischemia or hypoxia. Furthermore, in the control group, both myocardial blood flow and myocardial oxygen consumption remained constant (Table 1) .
With induction of ischemia, nutritional blood flow, determined with H 2 15 O (which includes the contribution of collateral supply), fell to a mean of 26 ± 12% of baseline (P < 0.005). Mean coronary perfusion pressure fell from 104 ± 25.9 mm Hg to 51.3 ± 18.2, (P < 0.05). With induction of hypoxia without reduction of pump flow, coronary perfusion pressure fell from a mean of 103 ± 6.6 to 77.1 ± 25.2 mm Hg, (P < .05), and there was an insignificant decline in myocardial nutritional blood flow, from 120 ± 12 ml/100 g per min to a mean of 100 ± 9 ml/100 g per min. MVO2 in the extracorporeally perfused region fell by 60.4% with ischemia (P < 0.005) and by 75.3% with hypoxia without ischemia (P < 0.005).
Myocardial Clearance of [
n C]Palmitate Ascertained from Residue Detection Tracer Time-Activity Curves Figure 1 illustrates regional myocardial residue time-activity curves from one dog in each of the experimental groups, early and late under control conditions (i.e., baseline and no intervention), ischemic perfusion, and hypoxic perfusion. The curves for "C activity comprise three main components as characterized previously: a vascular transit Circulation Research/VoZ. 57, No. 2, August 1985 component, an early phase of rapid clearance, and a late phase of slow clearance (Fig. 1 ).-The local slope of the early phase following the vascular transit component was analyzed for the interval from 1-3 minutes. Curve stripping was not employed. The late phase during the interval from 10-20 minutes after administration of tracer exhibited a relatively slow rate of clearance. The rate constants for the early rapid phase did not differ, either between early and late baseline studies in controls, or under initial baseline conditions, in each of the three groups (Table 2 ). With either ischemia or hypoxia, the ty, (ty, = In 2/k) for the early rapid clearance phase (1-3 minutes) lengthened significantly ( Table  2 ). The rate constants are shown for the early rapid phase of myocardial clearance (k E ) and for the late phase (k L ) for each of the three groups studied. Corresponding values are shown for the clearance of H 2 O (k H2 o) for the period 15-30 seconds after administration of tracer (Table 2) .
These data indicate that clearance of [ n C]palmitate was uninfluenced by extracorporeal coronary bypass perfusion per se. However, early clearance and late clearance of [ n C]palmitate were significantly reduced with ischemia or hypoxia ( Table 2) .
Although the early rapid phase of the myocardial residue [ CJpalmitate time-activity curve often has been considered to reflect oxidative metabolism of fatty acid directly (Goldstein et al., 1980; Lerch et al., 1982a; Schon et al., 1982a Schon et al., , 1982b , the association between ty, and 1/MVO 2 in the early rapid phase was not close (baseline studies n = 19, r = 0.45, y = l.Olx + 2.74; for all studies n = 36, r = 0.61, y = 1.91x + 2.26). The lack of a close correlation may be attributable to back-diffusion of nonmetabolized fatty acid reflected in the residue detection clearance curve. In support of this interpretation, the correlation between MVO 2 and efflux of n CO 2 was close (r = 0.83, n = 35, y = 2.08x + 0.124). Quantification of n CO 2 efflux measured di- The residual fraction of n C activity within myocardium after vascular transit of the injected bolus of labeled material was obtained by back extrapolation of the early component of the time-activity curve to the time of occurrence of peak counts. This value did not change over time under control conditions (36.2 ± 9.4% at baseline and 32.5 ± 6.5% late). With ischemia, it increased from 29.6 ± 9.8% to 41.2 ± 9.4% (P < 0.005). With hypoxia, it decreased insignificantly .from 27.9 ± 9.6 to 21.6 ± = rate of biological clearance of H,"O from 15-30 seconds after bolus administration of tracer, ke and k,. = rate constants for biological clearance of ("CJpalmitate for early (k^ 1-3 min) and late (k^ 10-20 min) intervals. Values = mean ± SD. Numbers for each group, see Table 1 . r = correlation coefficient of the slope.
by guest on January 3, 2018 http://circres.ahajournals.org/ Downloaded from 7.8%. However, net extraction, i.e., the product of residual fraction and flow, decreased significantly with both ischemia and hypoxia, as discussed below.
Fatty Add Metabolism Assessed Chemically and Radiochemically
Arterial free fatty acid levels did not differ significantly under baseline conditions in the three groups; neither did they change significantly under control conditions over time (Table 1) . With ischemia and with hypoxia, values were slightly but not significantly increased (Table 1) .
Net free fatty acid (FFA) extraction was calculated from the product of arteriovenous FFA concentration differences and flow. Net FFA extraction did not change significantly with perfusion held constant in controls. Baseline values in all three groups were similar (Table 1 ). With either ischemia or hypoxia, net myocardial extraction of FFA fell significantly (Table 1) .
To clarify interpretations of the data derived from analysis of efflux reflecting changes in clearance and residual n C activity, we undertook an analysis of tissue lipid pools. Myocardial samples obtained at the completion of experiments were analyzed for total FFA, FFA of specific chain length, and triglycerides. Tissue FFA levels were higher in extracorporeally perfused zones compared with values in normally perfused zones (native perfusion) in the same animals (Table 3) . With ischemia, FFA content increased in extracorporeally perfused compared with normal zones in the same animals, and compared with perfused zones in control animals (for both comparisons, P < 0.05) (Table 3) . Similarly, with hypoxia, FFA increased in extracorporeally perfused compared with normally perfused zones (P < 0.05) ( Table 3) .
Contributions of FFA of specific chain length to overall FFA are indicated in Table 3 . C16:0 comprised 25%, 18:0 comprised 22%; and 18:1 cornCirculation Research/Vol. 57, No. 2, August 1985 prised 33% of total FFA in normal regions. The most marked increases with ischemia and with hypoxia were seen for 16:0, 18:0, and 18:1 FFA (Table 3) . Thus, with either ischemia or hypoxia, tissue FFA content increased despite decreased net extraction in the same zones and despite modest increase in triglycerides. These results are compatible with reduced /3-oxidation of extracted fatty acid with ischemia or hypoxia as confirmed by the CO2 efflux data discussed below.
Triglyceride content was slightly but not significantly higher in zones of ischemia (29.4 ± 14.9 nmol/100 g) or hypoxia (26.8 ± 26.7 nmol/100 g), compared with values in normal zones in the same animals (25.0 ± 13.7 and 15.6 ± 8.9 nmol/100 g). The levels were significantly higher than those in normal zones of control animals (14.0 ± 7.9 nmol/ 100 g) (P < 0.05). These findings, based upon analysis of tissue content of unlabeled lipid fractions, support the interpretation of data derived from the analysis of the C-P residue time-activity curves. Thus, the diminished rate of clearance of tracer with ischemia or hypoxia ( Fig. 1 ) and the increased residue of tracer in the tissue at the end of 40 minutes (Fig. 2 ) are in keeping with an increase in the size of the FFA and slow turnover-lipid pools (triglyceride arid phospholipid) under these conditions.
Arteriovenous Lactate and Glucose
To assess the possible influence of altered metabolism of glucose or lactate on overall utilization of substrate under conditions of ischemia or hypoxia, net arteriocoronary venous glucose and lactate differences were measured. Under control conditions, neither glucose nor lactate extraction changed when perfusion was held constant. With ischemia or hypoxia, arteriovenous lactate differences reflected significant increases in the production of lactate (Table  1) . Negative values indicate net production. Arteriovenous glucose differences indicated no change The tissue content of individual fatty acids in the zones subjected to extracorporeal perfusion (ECB-perfused) is compared with that of myocardium supplied by the uninterrupted left anterior descending coronary artery (native pefusion). P indicates significance compared with native perfusion.
• 16:0 = palmitic acid, 16:1 = palmitoleic acid; 18:0 •= stearic acid, 18:1 « oleic acid, 18:2 = linoleic acid; 20:4 = arachidonic acid.
•f Extracorporeally bypass-perfused. u COi to overall radioactivity in the effluent (see Fig. 3 ), only 42% of initially extracted / " Q palmitate radioactivity remains within the tissue after 10 minutes and only 19% after 40 minutes. Despite the additional contribution attributable to back-diffusion of ^CJpalmitate with ischemia or hypoxia, the residue of p 1 Qpalmitate radioactivity in myocardium is substantially increased, consistent with the increases seen in free fatty acid and triglyceride pools.
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with control perfusion (70.4 ± 74.4 ^mol/100 ml for baseline studies; 71.0 ± 34.5 /tmol/100 ml for control studies). With ischemia or hypoxia, extraction of glucose tended to increase (103 ± 27.6 /tmol/100 ml with ischemia and 223 ± 84 ^mol/lOO ml with hypoxia, control n = 3, ischemia n = 5, hypoxia n = 3). Thus, despite the marked dog-to-dog variation with respect to glucose and lactate, ischemia or hypoxia tended to increase efflux of lactate and extraction of glucose.
The Contribution of Removal of Oxidative Metabolites of [ n C]Palmitate to Total Clearance of Tracer
Judging from assays of the n CO 2 and [ n C]palmitate arteriovenous differences in samples obtained throughout the data collection intervals, n CO 2 com-239 prised 87.8 ± 6.2% of radioactivity in the effluent from 1-20 minutes after injection of tracer in control studies. No differences (88.4 ± 3.1%) were seen in the late studies in the absence of an intervention (Table 4) . However, with ischemia, the mean percentage of n CO 2 with respect to total radioactivity in the effluent fell to 59.4 ± 11.0% (P < 0.01). It fell to 51.3 ± 16.2% with hypoxia (P < 0.005).
Analyses of the lipid extracts of the coronary venous effluent were performed in the seven animals in which ln CP and 1-14 CP were administered simultaneously. 14 C activity was present only in the FFA band following thin layer chromatography, and high pressure liquid chromatography (HPLC) analysis confirmed a single peak of activity corresponding with that of 16:0 fatty acid standard. These results confirm that the tracer in the effluent in these studies was in the form of unmetabolized radiolabeled palmitate. Figure 1 shows the results of sequential analyses of radioactivity in effluent throughout the data collection interval in animals in each of the three groups and with respect to the myocardial residue timeactivity curve. From Table 4 , it can be seen that maximal n CO 2 production occurred during the 1-to 10-minute interval corresponding to the phase of rapid early clearance. During the late phase of the curve (10-40 minutes), the proportion of n CO 2 in the effluent remained stable (Fig. 1) . With ischemia or hypoxia, back-diffusion of nonmetabolized fatty acid constituted a mean of 40.6% and 48.7% of activity in the effluent, respectively, compared to only 8.9% with no intervention (control). As indicated in Figure 1 , the proportions of radioactivity in the effluent constituted by n CO 2 and [ n C]palmitate were maintained constant throughout the latter part of the data collection interval (i.e., from 10-40 minutes after injection of tracer). Most n CO 2 production occurred in the early phase of clearance (1-10 minutes) (Table 4) . With hypoxia, the contribution of -C O 2 to total efflux is relatively greater during this 60.1 ± 3.1 45.2 ± 3.8 <0.05 50.4 ± 13.7 16.9 ± 9.8 O.001
42.7 ±9.0
15.1 ± 8.4 <0.0001
13.7 ± 2.9 14.7 ±6.5 NS 11.1 ±2.4 8.7 ±4.1 NS 11.6 ±4.8
6.8 ± 4.8 <0.05
1.1 ± 4.3 5.8 ±3.8 NS 5.8 ± 2.4 7.5 ± 3.8 NS 5.4 ±2.1 6.2 ± 2.1 <0.001 5.7 ± 1.9 6.2 ± 2.6 NS 10.7 ±6.9 15.6 ±8.9 <0.05 11.7 ±8.1 18.8 ± 10.2 <0.001
1.5 ±0.7 1.6 ±0.7 NS 0.9 ± 0.5 1.6 ±0.7 <0.05 2.4 ± 1.5 3.6 ± 1.5 NS 1.8 ± 1.2 1.1 ±0.7 NS 1.7 ±2.4 2.3 ± 0.7 <0.01
1.5 ±1.5 5.0 ± 2.4 <0.01
Composition of effluent (% "CO j ) = mean % of the radioactivity in effluent attributable to "COj (for the period 1-20 minutes). % of initially extracted ["CJpalmitate activity appearing as a function of time (as "CO2 or appearing unaltered as [l-"C]paImitate) = summed efflux for the intervals from 1-10, 10-20, and 20-40 minutes after administration of tracer, with respect to "C activity in myocardium at 1 minute. Mean values ± SD. Numbers in each group, see Table 1 phase (Fig. 1) , perhaps because of a larger and more heterogeneous volume of distribution with hypoxia (tissue perfusion and perfusion pressure fell despite maintained pump flow).
To assess the quantitative signficance of the efflux of n CO2, [ n C]palmitate, or both for each interval, radioactivity in the effluent was quantified and expressed with respect to [ n C]palmitate extracted by the tissue 1 minute after administration of tracer. The summed efflux of n CO 2 or [ n C]palmitate was comparable from dog to dog. The proportion of the myocardial residue activity appearing as n CO 2 in the interval from 1-10 minutes after administration of tracer averaged 49 ± 12% for baseline studies in all groups and was not significantly different, averaging 45.2 ± 4.8%, for the late studies in the control group. Values in the intervals from 10-20 or from 20-40 minutes after injection of tracer were similar under control conditions (Fig. 3) . However, with ischemia, the percentage of myocardial activity present in the tissue 1 minute after injection of tracer and subsequently appearing as 1 JCO 2 fell significantly (P < 0.001, 1-10 minutes) (Fig. 3) . Similarly, with hypoxia, it fell significantly during the same interval (P < 0.0001 compared with baseline values) (Fig. 3) . In addition, n CO 2 appearing in the intervals of 10-20 and 20-40 minutes expressed as a percentage of myocardial activity 1 minute after injection of tracer was reduced with ischemia or hypoxia ( Table 4) .
Efflux of nonmetabolized ["CJpalmitate during the interval from 1-40 minutes after injection of tracer constituted 9.0 ± 6.0% of initially extracted [''CJpalmitate under baseline conditions. It remained constant under control conditions (8.9 ± 7.2%). Efflux of nonmetabolized n C-P increased to 19.5 ± 9.4% with ischemia and to 27.4 ± 10.5% with hypoxia (P for both compared with baseline values < 0.05). Similarly, with ischemia or hypoxia, the efflux of nonmetabolized fatty acid was greater than that under control conditions during the intervals from 10-20 or 20-40 minutes after administration of tracer (Table 4) .
The distribution of the injected dose of n C-P was calculated for each time period, and the nonextracted component, the retained components, n C-P efflux, and n CO 2 efflux were analyzed (Fig. 4, A  and B) . It can be seen that after vascular transit, total clearance is diminished with ischemia, but n C-P efflux constitutes almost half of the subsequent clearance of activity. In contrast, in controls, CO 2 efflux comprises the major contribution to the subsequent clearance of activity.
These results indicate that efflux of radioactivity after the early vascular transit phase occurs primarily in the 1-to 10-minute interval after injection of radiotracer. Under control conditions, more than 80% of the radioactivity in the effluent reflects oxidative metabolism of fatty acid. The fraction of extracted [
n C]palmitate liberated as n CO 2 in the interval from 1-10 minutes after injection of tracer correlates with MVO 2 (r = 0.83). With ischemia or hypoxia, total clearance of tracer is reduced. With these interventions, nearly half of the total radioactivity in the effluent reflects back-diffusion of nonmetabolized fatty acid in the interval from 1-10 minutes after injection of tracer. Accordingly, the correlation between tv, and 1/MVO 2 (r = 0.61 for all studies) is less close. With ischemia or hypoxia, the fractional contribution from [ n C]palmitate to radioactivity in the effluent is increased in the intervals from 10-20 and 20-40 minutes after injection of tracer as well (Fig. 3) .
These results indicate that the proportion of initially extracted fatty acid retained in the tissue at the end of a 40-minute data collection interval differs markedly with ischemia and hypoxia, compared with results under control conditions. As shown in Figure 2 , even though total extraction falls with ischemia or hypoxia, the fraction of extracted fatty acid retained in the tissue, (as n C activity), increases markedly with both interventions. Thus, because of diminshed 0-oxidation, and despite back-diffusion, net clearance assessed from myocardial time-activity curves is reduced with ischemia or hypoxia
Discussion
The results of this study indicate that during the early phase of myocardial time-activity curves, clearance of administered [ n C]palmitate is directly related to oxidative metabolism of fatty acids reflected by efflux of n CO 2 . However, because of back-diffusion of nonmetabolized fatty acid, the relationship between clearance of total myocardial radioactivity and MVO 2 is not close. During the later phases of the residue detection time-activity curve from 10-40 minutes after administration of tracer, results are consistent with incorporation of the extracted fatty acid into phospholipid and triglyceride and with the measured rate of turnover of the combined, slowly turning over pools (Neely et al., 1972; Opie, 1976) .
Although the contribution of back-diffusion of nonmetabolized fatty acids to net clearance of myocardial radioactivity is modest under normoxic conditions, it becomes substantial with ischemia or hypoxia. Findings in this study indicate that unadjusted estimates of myocardial metabolism based solely upon residue detection indexes of clearance would overestimate oxidative metabolism of fatty acids in ischemic or hypoxic myocardium.
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Methodological Considerations
This study was designed to permit simultaneous determination of clearance of myocardial residual radioactivity assessed externally, extraction and clearance of radiolabeled fatty acid assessed directly, and delineation of the fractional contributions to declining radioactivity of oxidative metabolism (reflected by efflux of lf CO 2 ) and of back-diffusion of unaltered [
n C]palmitate. The /3-probe system utilized limited the potential zone in which time-activity curves could be determined to myocardium within 3-4 mm of the epicardial surface interfacing with the probe (Lerch et al., 1982b; Bergmann et al., 1984) . Intracoronary injection of tracer minimized the influence of recirculation of n CO 2 and [ n C]-palmitate which was evaluated directly by analysis of arterial input curves and incorporated in calculations. The contribution of recirculated 7-radioactivity from the myocardial blood pool was found to be insignificant after intracoronary administration of either [C]palmitate or H 2 O .
Myocardial nutritional blood flow was determined in zones perfused extracorporeally after intracoronary injection of H 2
15
O with a technique previously developed and validated in our laboratory (Lerch et al., 1982a (Lerch et al., , 1982b Bergmann et al., 1984) . After bolus intracoronary administration of the tracer, clearance (k H2 o) of the diffusable tracer H 2 15 O is dependent upon nutritional perfusion, the tissue/ blood partition coefficient for H 2 O (0.92 as previously measured, Bergmann et al., 1984) , and the specific gravity of myocardium 1.05 (Yipintsoi et al., 1972) . Calculations of tissue perfusion based upon H 2
O clearance closely match microsphere measurements over a wide range of flow (Bergmann et al., 1984) .
The metabolic status of the perfused myocardium was characterized by the direct Fick method for determination of regional oxygen utilization, total fatty acid extraction, extraction of individual fatty acids (C16 through C20) and extraction of glucose and lactate. Serial measurements under control conditions demonstrated that hemodynamics and overall myocardial oxidative metabolism remained constant throughout an interval of 130 minutes. Thus, hemodynamics, nutritional perfusion, oxygen utilization, extraction of lactate and glucose, myocardial extraction of [ n C]palrrutate and [ C]palmitate clearance, and n CO 2 and [ n C]palmitate efflux did not vary appreciably with time when aerobic perfusion was maintained constant.
Venous blood differs from arterial blood not only with respect to its lower oxygen content but also with respect to pH, Pco^ and the content of several metabolites. Although both the diminished oxygen content of venous blood and these factors may have influenced metabolism of myocardium subjected to hypoxic perfusion, previous studies with isolated hearts have demonstrated that no changes in fatty acid metabolism are exhibited when the pH of the perfusate is reduced to values as low as 7.1 with or without a concomitant increase in CO 2 (Opie, 1965) .
Kinetics of Myocardial Clearance Evaluated with Residue Detection Curves
As previously demonstrated by our group and by others, the myocardial residue time-activity curve after intracoronary injection of [ n C]palmitate can be deconvoluted into: (1) a very early phase of rapid vascular clearance, (2) an early phase of rapid clearance, and (3) late phase of slow clearance (Weiss et al, 1976; Lerch et al., 1982a,b; Schon et al., 1982a Schon et al., , 1982b . The present findings provide direct evidence based upon simultaneous kinetic and biochemical analyses that, under normoxic conditions, the early phase of rapid clearance of initially extracted fatty acids after intracoronary injection of tracer reflects oxidative metabolism of fatty acid.
In the present study, production of "CO 2 and efflux of [ CJpalmitate were determined directly, as was net extracted [ n C]palmitate 1 minute after injection of tracer. Results of the efflux studies demonstrated that only a small portion of extracted [ n C] palmitate was metabolized to n CO 2 within the first minute after the tracer was administered (1.3 ± 3.6%). They demonstrated, also, that under normoxic conditions, more than 85% of the total radioactivity in the effluent during the interval from 1-10 minutes after injection of tracer was present in the form of oxidation products of fatty acid. However, with ischemia or hypoxia, approximately 50% reflected back-diffusion of nonmetabolized fatty acid. With ischemia, the fraction of initially extracted [ n C]palmitate that appeared in the effluent as n CO 2 was markedly decreased from the 60.1% seen with normoxic perfusion to 16.9%. It was decreased to 15.1% with hypoxia in the corresponding 1-to 10-minute interval. Similarly, from 10-40 minutes, the fraction of extracted [ CJpalmitate appearing as CO 2 decreased from 21.4% with normoxic perfusion to 16.2% with ischemia and 13.0% with hypoxia. However, with either ischemia or hypoxia, the fractions of [''CJpalmitate radioactivity that appeared as back-diffused nonmetabolized fatty acid were significantly increased, particularly during the interval from 1-10 minutes (6.2% with normoxic perfusion, 15.6% with ischemia, 18.8% with hypoxia).
The net retention of "C activity in the tissue 40 minutes after administration of tracer was 19% under control conditions. However, 47% of initially extracted tracer remained in the tissue with ischemia and 44% with hypoxia (Fig. 2) . The increased retention is consistent with the reduced rate of residue clearance observed in the [ n C]palmitate time-activity curve ( Fig. 1 and Fig. 4, A and B) . Nevertheless, clearance of initially extracted carbon-11-labeled fatty acids assessed by positron tomography or with any imaging modality based upon residue detection of labeled fatty acid will be significantly influenced by back-diffusion of nonmetabolized fatty acids Circulation Research/Vol. 57, No. 2, August 1985 throughout the data collection period. Thus, images integrating data obtained relatively late, from 20-40 minutes after administration of tracer, will exhibit relatively high ratios of tracer in ischemic compared with normal zones, in contrast to images integrating data obtained early. This apparent paradox is the consequence of faster overall clearance of ["CJpalmitate from normoxic, well-perfused zones because of oxidative metabolism, in contrast to the slower overall clearance from ischemic or hypoxic zones attributable to both oxidation and back-diffusion of unaltered ["CJpalmitate. Analyses of lipid extracts corroborated this interpretation. Whereas most of the initially extracted fatty acid was oxidatively metabolized under normoxic conditions, substantial portions back-diffused or were retained as free or as esterified fatty acid under conditions of hypoxia or ischemia.
The results obtained indicate that estimates of metabolic activity based upon residue clearance of radiolabeled fatty acid underestimate the extent of the defect in oxidative metabolism. This effect is especially marked with ischemia or hypoxia when less than 60% of clearance may be accounted for by oxidative metabolism. The extent of the efflux of nonmetabolized tracer may be dependent not only upon tissue oxygenation but, also, upon numerous variables known to influence oxidative capacity and cellular integrity. Thus, the results of this study demonstrate that external assessments of oxidative metabolism of fatty acid based on analyses of residual clearance require consideration of the efflux of nonmetabolized tracer. Although the contributions of back-diffusion remained consistent within each of these study groups with defined conditions, the extent of back diffusion under more diverse circumstances requires further elucidation.
The following approaches may be useful in providing unambiguous remote interpretation of biological implications of observed rates of clearance of tracer: 1) Positron-emission tomography, permitting rapid data acquisition, and correction for partial volume effects, spillover, and gating to the cardiac cycle should enhance the accuracy of determinations of net fatty acid extraction during brief intervals of data acquisition early after administration of tracer. This will have the effect of minimizing the cumulative effects of back-diffusion and disparate rates of clearance from ischemic compared with normal zones; 2) With instrumentation which permits sufficient temporal resolution, extraction may be ascertainable from the measured input function of the tracer; and 3) Comparisons of extraction and clearance of ["CJpalmitate, and extraction of ["CJpalmitate analogs trapped by myocardium without undergoing oxidation during the data acquisition interval may provide independent indexes of the extent of back-diffusion under specific conditions.
